Scholarlink

Background <p>Behçet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease.</p> Objectives <p>Assessing effect of disease symptomatology and drugs used on sensorineural hearing loss severity.</p> Methods <p>In this study, 60 adult Behçet disease patients participated. All underwent a comprehensive medical history, a basic audiological assessment, a Behçet disease current activity form, and a tinnitus handicap inventory scale.</p> Results <p>Sixty percent of the participants, had sensorineural hearing loss; over half (55.6%) had mild sensorineural hearing loss, there is no statistically significant correlation between the duration, the Behçet disease current activity form score, the tinnitus handicap inventory scale, vascular symptoms, and sensorineural hearing loss.</p> Conclusions <p>Prevalence of sensorineural hearing loss is 60%. Auditory manifestations and hemoglobin (HB) level are independent factors for sensorineural hearing loss (SNHL), no relation between disease manifestation, duration, disease activity, drugs and severity of hearing loss, no relation between level of platelets, HB, total leukocyte count (TLC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and severity of hearing loss.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Behçet disease: do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月8日

查看全文
  • Dina Osman,
  • Mervat Bahiri,
  • Noha Hassan,
  • Yumn Elsabbagh

摘要

Background

Behçet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease.

Objectives

Assessing effect of disease symptomatology and drugs used on sensorineural hearing loss severity.

Methods

In this study, 60 adult Behçet disease patients participated. All underwent a comprehensive medical history, a basic audiological assessment, a Behçet disease current activity form, and a tinnitus handicap inventory scale.

Results

Sixty percent of the participants, had sensorineural hearing loss; over half (55.6%) had mild sensorineural hearing loss, there is no statistically significant correlation between the duration, the Behçet disease current activity form score, the tinnitus handicap inventory scale, vascular symptoms, and sensorineural hearing loss.

Conclusions

Prevalence of sensorineural hearing loss is 60%. Auditory manifestations and hemoglobin (HB) level are independent factors for sensorineural hearing loss (SNHL), no relation between disease manifestation, duration, disease activity, drugs and severity of hearing loss, no relation between level of platelets, HB, total leukocyte count (TLC), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and severity of hearing loss.